In this study, we demonstrate that agonistic anti-mCD27 can also be used to enhance the efficacy of other direct targeting mAb, such as anti-CTLA-4 and anti-CD25 in a colon adenocarcinoma tumour model. Here, CTLA4 is linked to colon adenocarcinoma.